
Purchase BMDP
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy BMDP for sale
BMDP, benzylone, is a recreational designer drug from the substituted cathinone family. It has been commonly encountered in seizures of street drug samples but appears to have relatively low potency and is mainly found as a component of mixtures with other related drugs.
Synthesized from the naturally occurring substance cathinone, BMDP is a recreational designer drug with low potency if ingested.
BMDP, also called Bela, is a designer drug from the phenethylamine family.
BMDP, often found in mixtures with other similar compounds, is a legal stimulant found in dietary supplements that a member of the Erowid Crew first encountered in April 2017.
BMDP is an investigational drug that is going through trials to help people with depression.
Benzylone (also known as 3,4-Methylenedioxy-N-benzylcathinone or BMDP) is a stimulant of the substituted cathinone family. It behaves as a norepinephrine–dopamine reuptake inhibitor and releases an agent of serotonin, norepinephrine and dopamine.
BMDP is a synthetic stimulant. It is commonly found in samples of street drugs and has relatively low potency on its own, mainly as a component of mixtures with other related drugs.
BMDP is a stimulant drug commonly found in street drug samples. It has low potency, but it can be easily bought over the counter.
BMDP is a synthetic stimulant commonly found in street drug samples.
BMDP is a synthetic stimulant with a chemical structure similar to methamphetamine.
BMDP is often found as a white to light brown powder and is formed by combining three chemicals- benzyl methyl ketone, dimethylaminoethanol and propionic acid.
3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic drug known for producing euphoria and empathy toward others.
Benzylone is a substituted cathinone and stimulant of the phenethylamine class that produces euphoria, local anesthetic and entactogenic effects when administered. It has been encountered in tablets with other components, such as 4-Methylaminorex, Buphedrone and Tramadol.
Benzylone is a recreational drug and entactogen of the phenethylamine class that produces euphoria, local anesthetic, and entactogenic effects.
A chemical from the amphetamine class, Beta-keto-amphetamine is a stimulant drug that has been shown to have both local anesthetic and hallucinogenic properties, typically producing disinhibition and euphoria.
Benzylone is a molecule first synthesized in 1928 by the pharmacologist Otto Eisleb (1893–1997) and structurally related to cathinone, an active ingredient found naturally in the plant Catha edulis.
Benzylone is a synthetic stimulant drug and substituted cathinone. It has been commonly encountered in seizures of street drug samples. However, it appears to have relatively low potency on its own, mainly found as a component of mixtures with other related drugs such as methcathinone and pentedrone.
BMDP is a non-psychoactive synthetic cannabinoid receptor agonist. It has been found in seized drug samples and may be sold at some parties as ecstasy, although it is often used alone without any drug adulteration since it has relatively low potency.
BMDP is a synthetic stimulant drug that induces euphoria, increased alertness and stimulation. It is described as having a shorter duration of action than methylone, ethylene and isobutylene; however, its effects are less pronounced, and it lacks the stimulatory effects of ethylene. BMDP was first synthesized in 2005 and sold online as a dietary supplement until a DEA ban on the sale of complements in 2006.
BMDP is the common name for a phenethylamine derivative of the stimulant drug congener 2-amino-3-(2,3-chlorophenyl)-1,2,4-triazole (BCPT). BMDP is not scheduled as an illegal substance in the United States or Canada.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
out of stock
100g $390
500g $1080
200g $590
1kg $1690
500g $1080
100g $390
100g $390
100mg $840
500g $1080
out of stock
1kg $1590